title: Intravitreal triamcinolone acetonide may increase the intraocular pressure even in vitrectomized eyes after more than 3 months.
authors.forename: Carsten H
authors.initials: CH
authors.lastname: Meyer
authors.forename: Stefan
authors.initials: S
authors.lastname: Mennel
authors.forename: Jörg C
authors.initials: JC
authors.lastname: Schmidt
mesh_terms: D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007267:Injections; D007429:Intraocular Pressure / Q000187:drug effects*; D009798:Ocular Hypertension / Q000139:chemically induced*; D013997:Time Factors; D014222:Triamcinolone Acetonide / Q000009:adverse effects*; D014821:Vitrectomy; D014822:Vitreous Body
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide